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Abstract
Background: The high burden of undiagnosed HIV in sub-Saharan Africa limits treatment and prevention efforts.
Community-based HIV testing campaigns can address this challenge and provide an untapped opportunity to identify non-
communicable diseases (NCDs). We tested the feasibility and diagnostic yield of integrating NCD and communicable
diseases into a rapid HIV testing and referral campaign for all residents of a rural Ugandan parish.
Methods: A five-day, multi-disease campaign, offering diagnostic, preventive, treatment and referral services, was
performed in May 2011. Services included point-of-care screening for HIV, malaria, TB, hypertension and diabetes. Finger-
prick diagnostics eliminated the need for phlebotomy. HIV-infected adults met clinic staff and peer counselors on-site; those
with CD4#100/mL underwent intensive counseling and rapid referral for antiretroviral therapy (ART). Community
participation, case-finding yield, and linkage to care three months post-campaign were analyzed.
Results: Of 6,300 residents, 2,323/3,150 (74%) adults and 2,020/3,150 (69%) children participated. An estimated 95% and
52% of adult female and male residents participated respectively. Adult HIV prevalence was 7.8%, with 46% of HIV-infected
adults newly diagnosed. Thirty-nine percent of new HIV diagnoses linked to care. In a pilot subgroup with CD4#100, 83%
linked and started ART within 10 days. Malaria was identified in 10% of children, and hypertension and diabetes in 28% and
3.5% of adults screened, respectively. Sixty-five percent of hypertensives and 23% of diabetics were new diagnoses, of
which 43% and 61% linked to care, respectively. Screening identified suspected TB in 87% of HIV-infected and 19% of HIV-
uninfected adults; 52% percent of HIV-uninfected TB suspects linked to care.
Conclusions: In an integrated campaign engaging 74% of adult residents, we identified a high burden of undiagnosed HIV,
hypertension and diabetes. Improving male attendance and optimizing linkage to care require new approaches. The
campaign demonstrates the feasibility of integrating hypertension, diabetes and communicable diseases into HIV initiatives.
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Introduction
There is a high burden of undiagnosed HIV in sub-Saharan
Africa, limiting treatment and prevention efforts. [1] Large-scale,
community-based HIV testing campaigns can address this
challenge and provide an untapped opportunity to identify non-
communicable diseases (NCDs). Multiple barriers to diagnosis are
shared across diseases, including inaccessible (i.e. expensive or
referral lab-based) diagnostics, lack of awareness about the need
for testing in persons with minimal or no symptoms of disease,
stigma, the high costs to villagers of accessing clinic-based testing
(including travel and time away from work), and inadequate or
non-existent primary care services. [2,3,4] Even after a diagnosis
of HIV, TB, malaria, hypertension or diabetes is made, linkage to
appropriate clinical care and treatment remains a problem.
[5,6,7,8] Through integration of services that can be shared
across multiple diseases, such as community mobilization for
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testing, active case finding, counseling and referral, many of these
barriers can be addressed efficiently and simultaneously. With a
broad array of point-of-care diagnostic technologies now available,
designing a multi-disease field laboratory has become practical.
We sought to test the feasibility and diagnostic yield of
integrating NCD and other communicable disease services into
a rapid, high-throughput, community-based HIV testing and
referral campaign for all residents of a rural Ugandan parish, and




The community health campaign was designed based on
collaboration between Makerere University – University of
California, San Francisco (MU-UCSF) investigators and the
Mulago-Mbarara Joint AIDS Program (MJAP) in Uganda, with
Ministry of Health (MOH) support. The campaign was imple-
mented in Kakyerere parish, Mbarara District, a rural community
in southwestern Uganda and designed to deliver free, high-
throughput (.1,000 residents/day), multi-disease services (Table 1)
to all parish residents over five days in May 2011. Staff members
were hired locally for a two-week period: one week for training on
campaign procedures (culminating in a one-day dress rehearsal of
the campaign procedures), and one week for the campaign. All
staff had prior training and work experience to match their role
within the campaign. The pre- and post-test counselors had
training and counseling experience from HIV clinics in Mbarara
municipality. The laboratory workers were hired from local public
and private clinical laboratories and were required to have, at a
minimum, basic skills in finger-prick based diagnostics including
rapid HIV-testing. Staff with interview questionnaire experience
and computer literacy performed consent procedures and
computer-based questionnaires, including symptom screening.
All staff members were fluent in the local language, Runyankole.
Campaign Setting and Pre-existing Health Services
Kakyerere Parish in Mbarara District is a rural community
composed of nine villages and 6,300 residents in southwestern
Uganda. The parish’s eastern boundary ends at Bwizibwera
trading centre (see Figure 1: map), a central market and public
gathering place that is the site of Bwizibwera Health Centre IV
(BWB HCIV), the primary government clinic for Kakyerere
residents. The western-most village in Kakyerere is nine kilometres
from BWB HCIV (see map). BWB HCIV offers diagnostic and
treatment services for HIV (including antiretroviral therapy),
active TB and pregnancy, as well as acute medical (e.g. malaria)
and surgical services. Though diagnostic services for hypertension
and diabetes are available, treatment of hypertension and diabetes
is not offered at BWB HCIV. The nearest government clinic
offering pharmacologic treatment for hypertension and diabetes is
located approximately 20 km from BWB HCIV at the Mbarara
University of Science and Technology (MUST) Hospital in
Mbarara Municipality.
Community Mobilization
All local village administrative councilors from Kakyerere
Parish were engaged in planning the campaign to ensure that
services addressed parish needs. They designed and executed
community mobilization activities one month before the cam-
paign, including church and mosque announcements, distribution
of posters, and radio announcements. To maximize participation
and reduce transport costs, campaign activities took place at three
well-known locations across the parish (Figure 1).
Laboratory Testing
Laboratory testing occurred in the field and in a central
laboratory in Mbarara municipality. The field laboratory offered
rapid point-of-care HIV antibody testing, diabetes screening and
malaria screening with a single finger-prick (Table 1). Blood
glucose measures were random, as neither fasting nor two-hour
measures were compatible with the high-throughput design. Point-
of-care (,20 minute) CD4+ cell count testing (PIMA, Inverness
Medical) was performed in all HIV-infected participants with an
additional finger-prick.
At the central laboratory, sputum microscopy and rapid PCR-
based, TB sputum testing (Xpert MTB/RIF Assay, Cepheid) were
performed. Sputum was collected from all consenting HIV-
infected adults, with induction using nebulized hypertonic saline
for participants unable to spontaneously produce sputum. All
sputum samples were brought to the central laboratory within
three hours of collection for evaluation. Samples that could not be
processed immediately were stored at 4uC.
Disease Screening
Definitions for a positive screening test for HIV, TB, malaria,
diabetes and hypertension are shown in Table 1.
Linkage to Care
Successful linkage to care was defined as attending at least one
appointment for a specific diagnosis in the three months after the
campaign.
Routine linkage. Participants with HIV, suspected TB,
hypertension or diabetes received post-test counseling and a
stipend to cover travel to clinic. HIV-infected participants met
with clinical staff and HIV-infected peer counselors on-site. HIV-
infected participants and HIV-uninfected TB suspects were
scheduled appointments at a local clinic (Bwizibwera Health
Centre) and offered enrollment in a linkage to care sub-study in
which they provided identifying information and agreed to be
located and interviewed should they not link to care. Appointment
scheduling took CD4 cell count into consideration, with earlier
appointments for participants with lower CD4 counts. Participants
with diabetes and hypertension were referred to a government
diabetes and hypertension clinic in Mbarara Municipality that
provides oral hypoglycemic and anti-hypertensive medications.
Enhanced linkage. HIV-infected participants with CD4
count #100 cells/mL were offered enrollment in an enhanced
strategy of rapid referral (,2 weeks post-campaign), expedited pre-
antiretroviral therapy (ART) counseling and ART initiation at first
clinic visit. The objective of the enhanced linkage pilot was to
determine if a government clinic that requires ART eligible
patients to attend three adherence counseling visits and to bring a
friend/relative as evidence of adherence support prior to ART,
could change its practices for a high-risk population. The strategy
of ART start at first clinic visit was piloted among participants with
CD4,100 so as to focus on those with the most advanced HIV
disease who are at highest risk of morbidity and mortality within a
short time frame.
Statistical Methods
Prevalence of each disease was calculated as a proportion with
the number of participants tested for each disease as the
denominator. Proportions were compared using the Pearson x2
test, means by the Student’s t-test, and medians by the Wilcoxon
HIV Campaigns and Non-Communicable Diseases
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rank sum test. Multivariable logistic regression was used to
evaluate risk factors for hypertension and diabetes, and predictors
of linking to care among newly diagnosed HIV-infected adults and
HIV-uninfected TB suspects. Independent variables for each
logistic regression analysis are described below and included age,
gender, and variables that were significantly associated with the
outcome of interest (p,0.1) on univariate analysis. Cost data are
reported based on actual expenditures incurred for each compo-
nent of the campaign (including equipment, salary, and facility
rental costs), and presented as costs per participant. We performed
all statistical analyses using Stata/SE version 12.
Ethical Statement
Campaign activities were anonymous. As written consent
requires recording of participants’ names and would have resulted
in confidential but not anonymous campaign participation, verbal
consent was obtained for participation. Children from 13–17 years
could provide verbal consent, consistent with Uganda MOH
policy. [9] Children ,13 years could not participate without a
parent/guardian present. The linkage to care sub-study required
written consent, as identifying information was collected. The
Makerere University School of Medicine Research and Ethics
Committee, the Ugandan National Council on Science and




Over five days in one week, 4,343 people attended the
campaign: 2,323 adults and 2,020 children (,18 years). Absolute
numbers of participants were highest in the central region of the
parish, with 984 people receiving services in one day. Participants
spent a median of 95 minutes (IQR: 71–129) at the campaign.
HIV-infected participants spent more time at the campaign (171
minutes [IQR: 136–216]) than HIV-uninfected participants (93
minutes [IQR: 70–125]).
Based on population projections from the 2002 Ugandan
Census that use an annual estimated growth rate of 2.16%, there
were an estimated 6,300 Kakyerere parish residents in 2011, with
50% of the population $18 years. [10] Therefore, an estimated
2,323/3,150 (74%) of adult residents, and 2,020/3,150 (69%) of
child residents, participated in the campaign. Of an estimated
Table 1. High Throughput Kakyerere Parish Community Health Campaign Services.
Service Category Service Population
Diagnosis HIV antibody testinga All participants
Point-of-care CD4+ testingb HIV+ participants
TB symptom screeningc All participants
Near point-of-care TB sputum screeningd HIV+ participants
Malaria screeninge Participants reporting fever in the past 24 hoursm
Diabetes screeningf Adult participants
Hypertension screeningg Adult participants
Prevention Pre- and Post-test counseling for HIV, suspected TB, malaria,
hypertension, and diabetes
All participants
TMP/SMX –30 day supplyh HIV+ participants
Male condoms Adult participants
Vitamin A 200,000 IUi Children: 6 months –5 years
Insecticide-treated bed netsj All households
Treatment Artemether-Lumefantrinek Malaria+ participants
Mebendazole 500 mgl Children: 1–5 years
Referral Routine scheduled appointments to a local health centre Participants with HIV, Suspected TB, Diabetes, or
Hypertension
Rapid appointments (,2 weeks) with expedited ART initiation HIV+ and CD4#100 cells/mL
aSerial testing algorithm, Uganda National Policy Guidelines for HIV Voluntary Testing and Counseling. [9] HIV rapid test kits: Determine HIV-1/HIV-2 (Abbot); HIV-1/2
Stat-Pak assay; and Uni-Gold HIV Rapid test.
bPIMA CD4 (Inverness). Indeterminate CD4+ cell count results were repeated once. Participants with two indeterminate CD4 results were counseled to undergo clinic-
based CD4 cell count testing.
cHIV+: WHO symptom screening algorithm (current cough, fever, sweats or weight loss) [28]; HIV-: cough .2 weeks.
dXpert MTB/RIF Assay (Cepheid) and direct fluorescent microscopy. Indeterminate Xpert assay results were repeated one time.
eParacheck Pf (P. falciparum) Rapid Test (Orchid Biomedical Systems).
fRandom blood glucose $11.1 mmol/L [32], HemoCue (Quest Diagnostics).
gSystolic blood pressure $140 mmHg or diastolic blood pressure $90 mmHg. [33] All blood pressure measures were performed using automated, electronic pressure
cuffs, with small, normal and large cuff sizes available. Blood pressure measures were performed one time; any participant with a positive screen underwent two repeat
measurements, including one manual blood pressure cuff measurement.
hWHO guidelines on co-trimoxazole prophylaxis for HIV-related infections [34].
iWHO guidelines on vitamin A supplementation [35].
jDistributed to all parish households after completion of the campaign.
kFor treating uncomplicated malaria. Severe malaria cases were provided transport to the nearest government hospital.
lWHO/Unicef guidelines, 2004 [36].
mCases of fever with hypotension were provided immediate transport to the nearest government hospital. HIV-uninfected participants with non-malarial fever were
counseled to seek further evaluation at the nearest government clinic.
doi:10.1371/journal.pone.0043400.t001
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Figure 1. Map of Kakyerere Parish. Location of Campaign Sites and the Relationship Between Prevalence of Undiagnosed Disease among Adult
Parish Residents and Increasing Distance from the Local Health Centre.
doi:10.1371/journal.pone.0043400.g001
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1,600 female and 1,550 male adult residents, 1,523 (95%) women
and 800 (52%) men attended. Among child residents, participation
rates were similar between girls and boys (1,066 girls and 954 boys
attended: 67% vs. 62%, respectively). Demographic characteristics
of campaign participants are shown in Table 2.
Active Case Finding
The burden of HIV, suspected TB, malaria, hypertension and
diabetes among campaign participants are shown in Table 3.
HIV. Among 2,323 adult participants, 2,282 (98%) underwent
HIV antibody testing, 12 (0.5%) declined and 29 (1.2%) were not
tested; 179/2,282 (7.8%) tested positive. Of 1,826 participants
aged 18 months –17 years, 10 (0.5%) tested HIV antibody positive.
Adult HIV prevalence was higher in women than men (9.2 vs.
5.2%, respectively; p = 0.001). 802 (35%) adults reported never
previously testing for HIV, and adults living in the central and
western parish regions reported significantly higher rates of never
HIV testing compared to adults living in the more urban eastern
region (with a trading and health centre; see Figure 1).
Among HIV-infected participants, 82/179 (46%) adults and 7/
10 children were newly diagnosed with HIV at the campaign. The
proportion of new HIV diagnoses was greater among HIV-
infected adults living in the western (54%) and central (48%)
regions, compared to those in the eastern region (34%), although
this difference was not statistically significant (p = 0.11).
CD4 cell counts were obtained in 167 (93%) HIV-infected
adults and the median CD4 count was 415 (IQR: 281–568) cells/
mL. Among adults not on ART, new HIV diagnoses had a higher
median CD4 count (449 cells/mL [IQR: 281–592]; n = 77) than
prior diagnoses (345 cells/mL [IQR: 279–521; n = 28), though the
difference was not statistically significant (p = 0.28).
Suspected TB. Among 179 HIV-infected adults, 155 (87%)
reported current cough, fever in the past 24 hours, any recent
weight loss or night sweats. 101 of 155 (65%) TB suspects agreed
to field sputum collection and produced sputum; all 101 tested
AFB smear negative, and 100 tested negative by the Xpert MTB/
RIF assay (with one indeterminate result).
Of HIV-uninfected adults, 392/2,103 (19%) reported a current
cough of .2 weeks duration. All 392 TB suspects received
counseling and referral with a transport stipend to the local health
centre for further evaluation.
Malaria. Of 1,331 children #10 years old, 531 (40%) had a
subjective fever reported by a parent or guardian over the
preceding 24 hours; 386 (73%) underwent malaria rapid
diagnostic testing (RDT), and 38 (10%) tested RDT positive. In
participants .10 years, 1,188/3,012 (39%) reported fever, 781/
1,188 (66%) underwent malaria RDT, and 23/781 (3%) tested
positive. Due to a RDT shortage on day two, 145 (27%) children
#10 years and 407 (34%) participants .10 years with fever were
not tested.
Hypertension. Of 2,323 adult participants, 2,278 (98%)
underwent hypertension screening and 645/2,278 (28%) had a
systolic blood pressure $140 mmHg, a diastolic blood pressure
$90 mmHg or reported a prior diagnosis of hypertension. 422
(65%) hypertensive adults reported no prior diagnosis of hyper-
tension. The prevalence of hypertension was similar among
women (29%) and men (27%; p = 0.4), and did not vary
significantly by region of residence (eastern (29%) vs. central
(25%) vs. western (30%); p = 0.19). Adults with hypertension
tended to be older (median age: 46 years [IQR: 35–60]) than those
without hypertension (32 years [24–45]; p,0.001), and have lower
education attainment (any education: 66% vs. 79%, respectively;
p,0.001). In a multivariate logistic regression model that included
age, sex, marital status and education attainment, only age
remained significantly associated with hypertension. The propor-
tion of new hypertensive diagnoses was significantly greater in
male (162/213 [76%]) than female participants (260/432 [60%],
p,0.001) and in residents of the central and western parish
regions compared to the eastern region (Figure 1).
Diabetes mellitus. Diabetes screening was performed in
2,283 (98%) adult participants, and 80 (3.5%) had a blood glucose
$11.1 mmol/L or reported a prior diagnosis of diabetes; 18/80
(23%) reported no prior diabetes diagnosis. Adults with diabetes
tended to be older (median age: 52 years [IQR: 37–65]) than those
without diabetes (35 years [25–48]; p,0.001), to own more land
(mean acres owned: 6.9 vs. 4.1; respectively; p = 0.002), to have
higher education attainment (completed primary school: 7.6% vs.
3.3%, respectively; p = 0.02), and to live in the eastern (4.4%) vs.
the central (2.2%) and western (2.7%) regions (p = 0.06). In a
Table 2. Demographic Characteristics of Kakyerere Parish
Community Health Campaign Participants.
All Participants N %
Age (median [IQR]), in years 19 [8–38]
Adults ($18 years) 2,323 53










Adult, age unknown 9 0.2
Total 4,343 100













Market Vendor 47 2
Other 354 15
Education Attainment
No schooling 569 24
Completed primary school 474 20
Completed secondary school 94 4
doi:10.1371/journal.pone.0043400.t002
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multivariate logistic regression model controlling for age, gender,
education, region of residence, and acres owned, older age
(OR = 1.72 for each decade increase, [95% CI: 1.45–2.04],
p,0.001), living in the eastern vs. central or western regions
(OR = 2.02 [95% CI: 1.17–3.50], p = 0.01) and having any
compared to no education (OR = 2.72 [95% CI: 1.10–4.70],
p = 0.03) remained positively associated with diabetes.
Linkage to Care
Of 82 adults with newly diagnosed HIV, six had CD4#100
cells/mL, 71 had CD4.100, and five had indeterminate CD4
counts. Of the 82 adults, 64 (78%) enrolled in the linkage to care
study: 58 in the routine strategy (including one with CD4 = 85 who
declined enhanced referral) and six in the enhanced strategy (five
with CD4#100 and one pregnant woman in her third trimester
with CD4 = 278). Of 18 adults with newly diagnosed HIV who did
not enroll in the linkage study, 13 were missed due to
implementation errors in the first two days of the campaign.
Two participants with CD4 counts of 106 and 4 cells/mL who
reported a prior HIV diagnosis but were not on ART also enrolled
in the enhanced strategy. Participants referred with the enhanced
strategy had a median CD4 count of 64 cells/mL (IQR: 22–97) vs.
441 cells/mL (IQR: 299–572) among routine referrals.
After routine referral, 20/58 (34%) adults with newly-diagnosed
HIV linked to HIV care within three months. After enhanced
referral, 6/8 (75%) adults linked to HIV care, including 5/6 (83%)
new diagnoses; all six participants linked within ten (median 2.5)
days of the campaign, screened negative for active TB by sputum
evaluation and/or clinician assessment, started ART at the first
clinic visit, and reported medication adherence four weeks after
starting ART. The odds of linking to care among new HIV
diagnoses decreased significantly with increased point-of-care
(POC) CD4 count (unadjusted OR: 0.80 for every 100 cell
increase in CD4 cell count, 95% CI: 0.64–1.00; p = 0.048); this
association remained significant after adjusting for age, sex, and
distance from clinic (adjusted OR: for every 100 cell increase in
CD4 count, 95% CI: ). There were no statistically significant
differences in age, sex, distance of residence from clinic, marital
status or symptoms between adults who did and did not link.
However, there was a non-significant trend towards increased
linkage in adults living closer to the local clinic (eastern region: 8/
16 (50%); central region: 14/32 (38%); western region: 2/10
(20%), linked to care; p = 0.30; among 58 adults with newly-
diagnosed HIV who provided location of residence data).
We attempted to track and interview 35 of the 39 adults with
newly diagnosed HIV who did not link to care: 20 could not be
located despite multiple attempts to find their homes, eight had
moved from Kakyerere parish (primarily to find work), five
provided reasons for not linking that suggested fear of stigma at the
health centre, one reported insufficient transport funds, and one
did not believe her HIV diagnosis was correct.
Among HIV-uninfected adult TB suspects, 252/392 (64%)
enrolled in the linkage to care sub-study. 130/252 (52%) linked to
care; all 130 produced sputum and tested AFB smear negative.
The unadjusted odds of linking to care for TB evaluation among
HIV-uninfected adults was higher with increasing age (OR: 1.3 for
every 10 years of age, 95% CI: 1.1–1.5; p,0.001), in women vs.
men (OR: 1.8, 95% CI: 1.1–3.0; p = 0.028), in married vs. single
adults (OR: 6.2, 95% CI: 2.0–18.7; p = 0.001), in persons
reporting night sweats vs. no night sweats (OR: 1.8, 95% CI:
1.1–3.1, p = 0.027) and in the eastern vs. western region (OR: 2.6,
95% CI: 1.2–5.5, p = 0.016). In a multivariate model including
these variables, the odds of linking to care remained higher with
increasing age (OR: 1.3 for every 10 years, 95% CI: 1.1–1.7;
p = 0.009), night sweats (OR: 2.0, 95% CI: 1.0–3.9; p = 0.047),
and residence in the eastern vs. western region (OR: 3.0, 95% CI:
1.3–6.8; p = 0.009).
Among 422 adults with newly diagnosed hypertension, 249
(59%) accepted referral appointments and 107 (43%) linked to
care within three months. All 18 adults with newly diagnosed
diabetes accepted referral appointments and 11 (61%) linked
within three months.
Campaign Costs
The cost of providing the full multi-disease campaign and
evaluation was $37.82 (2011 US dollars) per participant. The cost
of providing HIV counseling and testing (HCT) alone (including
costs of the high throughput community campaign infrastructure)
was $8.27 per participant. The cost of combined HIV services at
the campaign, including HCT, POC CD4 ($16.42/participant),
trimethoprim-sulfamethoxazole ($0.02/participant), and linkage to
care services (including travel stipends) was $26.69 per participant.
The incremental cost of adding components on top of the
combined HIV services was $2.41 for diabetes and hypertension
screening, $4.58 for TB screening (including rapid, PCR-based TB
testing), and $2.11 for malaria rapid diagnostic testing, treatment
and insecticide-treated bednets.
Discussion
Our campaign demonstrates the feasibility of integrating
communicable and non-communicable disease (NCD) screening
into a community-wide HIV testing drive in rural Africa. The
campaign reached 74% of adults in a community of 6,300 people
rapidly (in five days) with efficient, high-throughput (95 minutes/
person) use of point-of-care diagnostics. We identified a high
burden of undiagnosed diseases using active case finding, even
though multi-disease diagnostic capacity existed prior to the
campaign at a nearby, local clinic. Active screening resulted in
detection of HIV cases at high CD4 counts (median: 415), well
above country guidelines for ART initiation. [11] Improving male
attendance and optimizing linkage to care rates require new
approaches.
In contrast to health campaigns that focus efforts on a single
disease or demographic or that require intensive resources for
home-based testing, we focused on overcoming barriers to
diagnosis and referral that are shared by multiple diseases in
resource-limited settings. [12] These barriers include community
participation, field laboratory infrastructure, access to trained
counselors, and referral services. Furthermore, by combining
services in a public setting, HIV testing is normalized as a routine
part of health care, thus reducing stigma. Importantly the
campaign represents a step forward in the rapid scale-up of
integrated communicable and non-communicable disease services
in a rural African setting, and builds on the prior successes of high-
throughput HIV-testing campaigns. [13]
The cost estimate for the full multi-disease campaign ($37.82/
participant) reflects start-up and research evaluation costs; these
costs will decrease with more widespread implementation,
increased number of people tested and streamlining. Our initial
cost estimates are slightly less than published costs for an HIV
counseling and testing (HCT) campaign with water filter and
bednet distribution in rural Kenya ($40.66/person), [14] and the
cost of HCT services alone using our community campaign
approach is comparable to estimates of door-to-door HCT. [12]
Community-based testing offers additional advantages by serving
as a platform for multi-disease delivery. The relatively low cost of
adding NCD screening to community-based HIV testing cam-
HIV Campaigns and Non-Communicable Diseases
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paigns ($2.41/person) highlight this latter advantage. This study
does not address the cost-effectiveness of adding NCD screening,
but the relatively low cost of $2.41/person makes it likely to be
cost-effective. Furthermore, the early HIV diagnoses made
possible by the campaign (i.e. a median CD4 of 499 cells/mL
among new HIV diagnoses), could result in substantial benefit
through reductions in morbidity and mortality, as well as HIV
transmission, particularly if coupled with earlier ART initiation.
We identified a substantial burden of hypertension and diabetes
in this population; further evidence that NCDs are a global health
threat rather than a problem of high-income countries alone. [15]
Our estimates of hypertension and diabetes prevalence are within
the range of published estimates for east Africa. [16,17,18]_EN-
REF_14 NCD burden will increase with urbanization and ageing
of populations worldwide, [19] and our results reflect this;
increasing age was associated with hypertension and diabetes,
and higher education attainment was associated with diabetes. At
a recent high-level United Nations meeting to address the growing
global NCD crisis, priorities for action focused on prevention (e.g.
tobacco control, salt reduction), primarily at the national level.
[20] These priorities are important, but do little for individuals
already living with NCDs._ENREF_23 We show that HIV testing
and referral can be leveraged in rural Africa to find and engage
patients with undiagnosed NCDs, though capacity for NCD
treatment remains limited. The substantial investment in HIV
infrastructure in sub-Saharan Africa presents an important
opportunity and an immediate way forward for delivering NCD
care in resource-limited settings.
Linkage to care after referral was insufficient and undermines
the benefits of early diagnosis. Low rates of linkage to care after an
HIV diagnosis and loss to follow-up are common in Africa, due in
part to the large number of steps between diagnosis and ART
initiation, including send-out CD4 count testing. [7] Point-of-care
(POC) CD4 count testing can reduce time to ART start in patients
enrolled in HIV care and those diagnosed with HIV in a clinical
setting. [21,22] We used POC CD4 with community-based HIV
testing to triage referrals based on CD4 count and to accelerate
ART start (,10 days post-diagnosis) in a small, pilot group of
high-risk patients (CD4,100). Future interventions are needed to
optimize linkage to care for HIV-infected persons living in remote
areas, including de-centralized, streamlined care and re-engage-
ment for those who have dropped out of care.
Our estimation of linkage to care has several limitations. First,
we measured linkage to care at a single clinic, BWB HCIV, and
defined successful engagement in care as an initial visit within
three months of diagnosis. Residents may have sought HIV,
hypertension or diabetes care elsewhere, or engaged in care later
than three months after diagnosis, resulting in underestimation of
linkage. Second, linkage to an initial clinic appointment may not
result in sustained engagement in care, and assessment of the long-
term health effects of early HIV or NCD diagnosis is beyond the
scope of this analysis. However, even without long-term outcome
data, active community-based HIV and NCD diagnoses and
linkage to a first clinic visit remain steps required for successful
engagement in care and are likely to have a sustained impact on
HIV and NCD control in this community. [23,24,25]
Increasing adult male participation and optimizing TB case
finding are two challenges that future campaigns will address. A
high proportion of adult parish residents participated, but men
attended at far lower levels than women, consistent with prior
studies of HIV testing. [13,26] Male reticence to participate in
health care, perceptions of illness as a sign of weakness and
vulnerability, and extended work hours that conflicted with the
campaign’s schedule may account for lower male participation.
[26,27] More research is needed to clarify obstacles and evaluate
incentives to increase male participation. Future campaigns will
pilot a day exclusively for men to undergo testing, syphilis
screening, and hours to accommodate work schedules.
With WHO guideline-based TB symptom screening designed to
exclude active TB, we successfully identified 13% of HIV-infected
adults for safe initiation of isoniazid preventive therapy (IPT). [28]
However, the high prevalence of TB symptoms in this rural setting
(19% of HIV-uninfected adults) resulted in large numbers of TB
suspects requiring further lab-based evaluation. The Xpert MTB/
RIF assay was used to evaluate HIV-infected TB suspects, but no
Xpert-positive TB cases were identified, likely due to the number
screened (100 suspects); the expected prevalence of newly
diagnosed TB among HIV-infected persons in population-based
surveys is ,1% in resource-limited settings. [29] Cases may have
also been missed as the sensitivity of the Xpert assay from a single
sample in smear negative TB is 43–72%, and lower in HIV-
infected than uninfected persons. [30,31] Further investigation is
needed into TB diagnostic algorithms following positive symptom
screening and improving diagnostics for settings where MTB
culture is not available. In addition, with the low rate of linkage to
care after positive symptom screening and the low yield of active
TB in HIV-uninfected campaign participants, novel active TB
case finding strategies are needed that account for local HIV and
TB epidemiology.
At this juncture, given the substantial investment in HIV
infrastructure in sub-Saharan Africa to date, there is a widespread
opportunity to leverage HIV infrastructure for integrated disease
management. The numerous lessons learned from HIV prevention
and treatment implementation can and should be a basis for
management of chronic diseases, including the growing NCD
burden in Africa. Our campaign represents a community-wide
effort to jump-start the process of integration.
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